We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




DNA Synthesis Visualized in Whole Animals

By LabMedica International staff writers
Posted on 03 Jan 2012
Swiss scientists have discovered a new substance for labeling and visualization of DNA synthesis in vivo in whole animals. More...


Applications for this technique include identifying the sites of virus infections and cancer growth, due to the profusion of DNA replication in these tissues. This strategy should therefore lead to new applications in drug development.

Interactions of biologic macromolecules are the fundamental bases of living systems. Biologic macromolecules are synthesized in living cells by linking many small molecules together. Naturally occurring macromolecules include genetic materials (DNA) and proteins. A precise determination of the synthesis of these macromolecules in whole animals is a basic prerequisite for better understanding biologic systems, and for the development of new therapeutic strategies.

To visualize the synthesis of biomolecules in living organisms, synthetic small molecules can be added to and integrated by the cell’s own biosynthetic processes. Consequently, the engineered biomolecules containing the synthetic units can be selectively labeled with fluorescent compounds. Until now, this approach had one major drawback: the substances used for labeling were toxic and caused cell death.

Anne Neef, a PhD student from the Institute of Organic Chemistry at the University of Zurich (Switzerland), has devised a new compound that can replace the natural nucleoside thymidine in DNA biosynthesis. This fluorinated nucleoside called F-ara-Edu labels DNA with little or no impact on genome function in living cells and even whole animals. F-ara-Edu is less toxic than previously reported compounds used for DNA labeling and it can be detected with greater sensitivity.

F-ara-Edu is therefore perfectly suited for experiments aimed at “birth dating” DNA synthesis in vivo. “As a demonstration of this, F-ara-Edu was injected into Zebrafish eggs immediately after fertilization. Following development and hatching of the fish, the very first cells undergoing differentiation in embryonic development could be identified,” explained Ms. Neef’s research advisor, Prof. Nathan Luedtke. “By visualizing new DNA synthesis in whole animals, the sites of virus infection and cancerous growth can be identified due to the abundance of DNA replication in these tissues,” added Prof. Luedtke. This strategy should therefore lead to new strategies in drug development.

Related Links:

University of Zurich



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.